Patents by Inventor Franck Skobieranda

Franck Skobieranda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GHB DOSING
    Publication number: 20240285560
    Abstract: Provided herein are methods of administering GHB formulations for the treatment of narcolepsy and other conditions.
    Type: Application
    Filed: May 1, 2024
    Publication date: August 29, 2024
    Inventor: Franck SKOBIERANDA
  • SODIUM OXYBATE TO TREAT IDIOPATHIC HYPERSOMNIA
    Publication number: 20230404950
    Abstract: The present disclosure relates to methods of treating idiopathic hypersomnia with oxybate, preferably sodium oxybate.
    Type: Application
    Filed: October 8, 2021
    Publication date: December 21, 2023
    Inventors: Franck SKOBIERANDA, Dan CHEN, Amanda Leigh STERKEL
  • TREATMENT METHODS USING GHB
    Publication number: 20230390228
    Abstract: Provided herein are methods of treating fibromyalgia, post-traumatic stress disorder, irritable bowel syndrome, and irritable bowel disease in a patient with a slow wave sleep deficit by administering oxybate or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: October 18, 2021
    Publication date: December 7, 2023
    Applicant: Jazz Pharmaceuticals Ireland Limited
    Inventors: Franck SKOBIERANDA, Mark Toddman KIRBY
  • METHODS OF TREATING IDIOPATHIC HYPERSOMNIA
    Publication number: 20220008367
    Abstract: The present disclosure relates to methods of treating idiopathic hypersomnia with oxybate, preferably a mixture of salts of oxybate (a mixed salt oxybate).
    Type: Application
    Filed: February 22, 2021
    Publication date: January 13, 2022
    Inventors: Franck SKOBIERANDA, Dan CHEN, Amanda Leigh STERKEL, Cuiping CHEN, Patricia CHANDLER
  • GHB DOSING
    Publication number: 20210361601
    Abstract: Provided herein are methods of administering GHB formulations for the treatment of narcolepsy and other conditions.
    Type: Application
    Filed: August 6, 2021
    Publication date: November 25, 2021
    Applicant: JAZZ PHARMACEUTICALS IRELAND LIMITED
    Inventor: Franck SKOBIERANDA
  • METHODS FOR TREATING OR PREVENTING ASTHMA BY ADMINISTERING AN IL-4R ANTAGONIST
    Publication number: 20210322546
    Abstract: The invention provides methods for treating or preventing asthma and associated conditions in a patient. The methods featured in the invention comprise administering to a subject in need thereof a therapeutic composition comprising an interleukin-4 receptor (IL-4R) antagonist, such as an anti-IL-4R antibody.
    Type: Application
    Filed: March 29, 2021
    Publication date: October 21, 2021
    Inventors: Gianluca Pirozzi, Franck Skobieranda, Yongtao Li, Neil Graham, Steven P. Weinstein
  • GHB DOSING
    Publication number: 20210186907
    Abstract: Provided herein are methods of administering GHB formulations for the treatment of narcolepsy and other conditions.
    Type: Application
    Filed: December 22, 2020
    Publication date: June 24, 2021
    Inventor: Franck SKOBIERANDA
  • METHODS FOR TREATING OR PREVENTING ASTHMA BY ADMINISTERING AN IL-4R ANTAGONIST
    Publication number: 20190125865
    Abstract: The invention provides methods for treating or preventing asthma and associated conditions in a patient. The methods featured in the invention comprise administering to a subject in need thereof a therapeutic composition comprising an interleukin-4 receptor (IL-4R) antagonist, such as an anti-IL-4R antibody.
    Type: Application
    Filed: October 11, 2018
    Publication date: May 2, 2019
    Inventors: Gianluca Pirozzi, Franck Skobieranda, Yongtao Li, Neil Graham, Steven P. Weinstein
  • Methods for treating or preventing asthma by administering an IL-4R antagonist
    Patent number: 10137193
    Abstract: The invention provides methods for treating or preventing asthma and associated conditions in a patient. The methods featured in the invention comprise administering to a subject in need thereof a therapeutic composition comprising an interleukin-4 receptor (IL-4R) antagonist, such as an anti-IL-4R antibody.
    Type: Grant
    Filed: February 20, 2015
    Date of Patent: November 27, 2018
    Assignees: Sanofi Biotechnology, Regeneron Pharmaceuticals, Inc.
    Inventors: Gianluca Pirozzi, Franck Skobieranda, Yongtao Li, Neil Graham, Steven P. Weinstein
  • METHODS FOR TREATING OR PREVENTING ASTHMA BY ADMINISTERING AN IL-4R ANTAGONIST
    Publication number: 20150246119
    Abstract: The invention provides methods for treating or preventing asthma and associated conditions in a patient. The methods featured in the invention comprise administering to a subject in need thereof a therapeutic composition comprising an interleukin-4 receptor (IL-4R) antagonist, such as an anti-IL-4R antibody.
    Type: Application
    Filed: February 20, 2015
    Publication date: September 3, 2015
    Inventors: Gianluca Pirozzi, Franck Skobieranda, Yongtao Li, Neil Graham, Steven P. Weinstein